AdaptHealth CCO sells 11,275 shares in planned trade

AdaptHealth Corp. Chief Commercial Officer Russell E. Schuster III sold 11,275 shares of Common Stock on June 1, 2026 at $10.06 per share in an open-market transaction.

Rhea-AI Filing Summary

AdaptHealth Corp. Chief Commercial Officer Russell E. Schuster III sold 11,275 shares of Common Stock on June 1, 2026 at $10.06 per share in an open-market transaction. The sale occurred automatically under a Rule 10b5-1 trading plan adopted on March 2, 2026.

After this transaction, he directly holds 136,538 shares of AdaptHealth Common Stock, indicating that the sale represents only a portion of his overall stake.

Insider Trade Summary 10b5-1

Net Seller: 11,275 shares

Net Sell 1 txn

Insider Schuster III Russell E.

Role Chief Commercial Officer

Sold 11,275 shs ($113K)

Type	Security	Shares	Price	Value
Sale	Common Stock	11,275	$10.06	$113K

Holdings After Transaction: Common Stock — 136,538 shares (Direct)

Footnotes (1)

1. F1. The sale reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2026.

Key Figures

Shares sold: 11,275 shares Sale price per share: $10.06 Shares held after sale: 136,538 shares +2 more

5 metrics

Shares sold 11,275 shares Common Stock open-market sale on June 1, 2026

Sale price per share $10.06 Price for Common Stock sale on June 1, 2026

Shares held after sale 136,538 shares Direct Common Stock holdings following the transaction

Sell transactions count 1 transaction Non-derivative sale reported in this Form 4

Net shares sold 11,275 shares Net buy/sell direction is net-sell in transaction summary

Key Terms

Common Stock, open-market sale, Rule 10b5-1 trading plan, Form 4

4 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Rule 10b5-1 trading plan regulatory

"occurred automatically pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Form 4 regulatory

"The sale reported in this Form 4 occurred automatically"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AdaptHealth (AHCO) executive Russell E. Schuster III report in this Form 4?

Russell E. Schuster III reported an open-market sale of 11,275 shares of AdaptHealth Common Stock at $10.06 per share. The transaction was disclosed on Form 4 as required for company officers under U.S. securities regulations.

How many AdaptHealth (AHCO) shares did the CCO sell and at what price?

The Chief Commercial Officer sold 11,275 shares of AdaptHealth Common Stock at a price of $10.06 per share. This sale was categorized as an open-market transaction, reflecting a standard market trade rather than a private or derivative-related deal.

How many AdaptHealth (AHCO) shares does the insider hold after the reported sale?

Following the sale, Russell E. Schuster III holds 136,538 shares of AdaptHealth Common Stock directly. This post-transaction balance shows that he retained a substantial ownership position in the company after disposing of 11,275 shares.

Was the AdaptHealth (AHCO) insider sale made under a Rule 10b5-1 plan?

Yes. The sale occurred automatically under a Rule 10b5-1 trading plan adopted on March 2, 2026. Such plans pre-schedule trades, helping executives diversify holdings while reducing concerns about trading on non-public information.

What type of transaction is reported for AdaptHealth (AHCO) in this Form 4?

The Form 4 reports a non-derivative open-market sale of AdaptHealth Common Stock. It involves direct ownership shares, not options or other derivatives, and is classified with transaction code “S” for sale in the SEC reporting framework.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 06:43 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schuster III Russell E.

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		S(1)		11,275	D	$10.06	136,538	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2026.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on February 4, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Russell Schuster	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)